FDA warns of foot, leg amputations with J&J diabetes drug - Reuters

Reuters

FDA warns of foot, leg amputations with J&J diabetes drug Reuters Johnson & Johnson (JNJ.N) is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration said on Tuesday. Final results from two clinical trials showed leg and foot ... Lilly Could Grab Diabetes Share From Dow's J&J On Amputation WoesInvestor's Business Daily FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug LabelRegulatory Focus Diabetes drug raises risk of foot and leg amputationConsumerAffairs The Pharma Letter (registration) -HealthDay -Diabetes.co.uk -FDA all 31 news articles »